AI-Driven Innovations in Fintech: Applications, Challenges, and Future Trends
International Journal of Electrical and Computer Engineering Research · 15.03.2025 · 5 (1) · 8-15
DOI: 10.53375/ijecer.2025.437 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Electrical and Computer Engineering Research, online erschienen am 15.03.2025. Verfasst von Asifiqbal Saiyed. Die Arbeit wurde bisher 22-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Integrating Artificial Intelligence (AI) and Machine Learning (ML) in fintech has revolutionized trading, risk management, fraud detection, and regulatory compliance. AI-driven automation enhances efficiency, while predictive analytics improves market forecasting and decision-making. Case studies demonstrate significant transformations in financial institutions, reducing operational costs and increasing accuracy. However, challenges such as data security, model interpretability, and bias remain critical concerns. This paper explores the impact of AI and ML in fintech, analyzing their benefits, limitations, and future implications for practitioners and regulators. Recommendations for improving AI transparency and regulatory adaptability are also discussed.
Zitieren
APA
Saiyed, A. (2025). AI-Driven Innovations in Fintech: Applications, Challenges, and Future Trends. International Journal of Electrical and Computer Engineering Research, 5(1), 8-15. https://doi.org/10.53375/ijecer.2025.437
Vancouver
Saiyed A. AI-Driven Innovations in Fintech: Applications, Challenges, and Future Trends. International Journal of Electrical and Computer Engineering Research. 2025;5(1):8-15. doi:10.53375/ijecer.2025.437
BibTeX
@article{Saiyed2025,
author = {Saiyed, Asifiqbal},
title = {AI-Driven Innovations in Fintech: Applications, Challenges, and Future Trends},
journal = {International Journal of Electrical and Computer Engineering Research},
year = {2025},
volume = {5},
number = {1},
pages = {8--15},
doi = {10.53375/ijecer.2025.437}
}
EUVIMED